View Older Stories View More Recent Stories

Sep 15, 2022 08:30AM Surgalign Announces Third Clinical Site in the Commercialization of its HOLO Portal™ Surgical Guidance System
Sep 15, 2022 08:30AM Surgalign Announces Third Clinical Site in the Commercialization of its HOLO Portal™ Surgical Guidance System
Sep 8, 2022 02:00PM Surgalign to Exhibit at the Society for Minimally Invasive Spine Surgery (“SMISS”) Annual Forum and the North American Spine Society (“NASS”) 2022 Annual Meeting
Sep 8, 2022 02:00PM Surgalign to Exhibit at the Society for Minimally Invasive Spine Surgery (“SMISS”) Annual Forum and the North American Spine Society (“NASS”) 2022 Annual Meeting
Aug 24, 2022 08:30AM Surgalign Announces FDA 510(k) Clearance of the Cortera™ Spinal Fixation System – The Company’s New Flagship Posterior Fixation Platform
Aug 24, 2022 08:30AM Surgalign Announces FDA 510(k) Clearance of the Cortera™ Spinal Fixation System – The Company’s New Flagship Posterior Fixation Platform
Aug 10, 2022 08:32AM Surgalign Holdings (SRGA) Enters Global Settlement Agreement with Resolve Surgical Technologies and RTI Surgical
Aug 10, 2022 08:30AM Surgalign Announces Global Settlement Agreement with Resolve Surgical Technologies and RTI Surgical, Inc.
Aug 10, 2022 08:30AM Surgalign Announces Global Settlement Agreement with Resolve Surgical Technologies and RTI Surgical, Inc.
Aug 9, 2022 04:01PM Surgalign Holdings, Inc. Announces Second Quarter 2022 Results and Reiterates Full Year 2022 Revenue Guidance Range
Aug 9, 2022 04:01PM Surgalign Holdings, Inc. Announces Second Quarter 2022 Results and Reiterates Full Year 2022 Revenue Guidance Range
Aug 4, 2022 08:30AM Surgalign Names Paolo Amoruso Chief Legal Officer and Corporate Secretary
Aug 4, 2022 08:30AM Surgalign Names Paolo Amoruso Chief Legal Officer and Corporate Secretary
Aug 3, 2022 05:34PM Surgalign Reaches Settlement with the Securities and Exchange Commission on Matters Related to Prior Management Between 2015-2019
Aug 3, 2022 05:34PM Surgalign Reaches Settlement with the Securities and Exchange Commission on Matters Related to Prior Management Between 2015-2019
Aug 1, 2022 08:30AM Surgalign Schedules Second Quarter 2022 Earnings Release for August 9, 2022
Aug 1, 2022 08:30AM Surgalign Schedules Second Quarter 2022 Earnings Release for August 9, 2022
Jul 20, 2022 08:30AM Surgalign Announces the Commercial Relaunch of its Next Generation CervAlign Anterior Cervical Plate System Optimized for Discectomy and Fusion Procedures
Jul 20, 2022 08:30AM Surgalign Announces the Commercial Relaunch of its Next Generation CervAlign Anterior Cervical Plate System Optimized for Discectomy and Fusion Procedures
Jul 14, 2022 08:30AM Surgalign Announces Partnership with PRIA Healthcare to Improve Patient Healthcare Coverage
Jul 14, 2022 08:30AM Surgalign Announces Partnership with PRIA Healthcare to Improve Patient Healthcare Coverage
Jul 6, 2022 04:30PM Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Jul 6, 2022 04:30PM Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Jul 6, 2022 09:07AM Surgalign Holdings (SRGA) Announces Clinical Site Expansion in the Commercialization of HOLO Portal
Jul 6, 2022 09:00AM Surgalign™ Announces Clinical Site Expansion in the Commercialization of its HOLO Portal™ Surgical Guidance System in Ohio
Jul 6, 2022 09:00AM Surgalign™ Announces Clinical Site Expansion in the Commercialization of its HOLO Portal™ Surgical Guidance System in Ohio
Jun 3, 2022 09:00AM Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Jun 3, 2022 09:00AM Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
May 16, 2022 09:00AM Surgalign Holdings (SRGA) Announces 1:30 Reverse Stock Split
May 16, 2022 09:00AM Surgalign Holdings, Inc. Announces 1-for-30 Reverse Stock Split
May 16, 2022 09:00AM Surgalign Holdings, Inc. Announces 1-for-30 Reverse Stock Split
May 10, 2022 04:01PM Surgalign Holdings, Inc. Announces First Quarter 2022 Results and Raises Full Year 2022 Revenue Guidance Range
May 10, 2022 04:01PM Surgalign Holdings, Inc. Announces First Quarter 2022 Results and Raises Full Year 2022 Revenue Guidance Range
May 6, 2022 09:00AM Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
May 6, 2022 09:00AM Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
May 5, 2022 09:05AM Surgalign Holdings (SRGA) Announces the First Successful Surgical Procedure Utilizing its HOLO Portal™ Surgical Guidance System
May 5, 2022 09:00AM Surgalign™ Announces the First Successful Surgical Procedure Utilizing its HOLO Portal™ Surgical Guidance System
May 5, 2022 09:00AM Surgalign™ Announces the First Successful Surgical Procedure Utilizing its HOLO Portal™ Surgical Guidance System
Apr 26, 2022 04:30PM Surgalign Holdings, Inc. Schedules First Quarter 2022 Earnings Release for May 10, 2022
Apr 26, 2022 04:30PM Surgalign Holdings, Inc. Schedules First Quarter 2022 Earnings Release for May 10, 2022
Apr 5, 2022 04:30PM Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Apr 5, 2022 04:30PM Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Mar 24, 2022 09:00AM New EVoluSIon Study Data Demonstrates Strong Support for the SImmetry® Sacroiliac Joint Fusion System
Mar 24, 2022 09:00AM New EVoluSIon Study Data Demonstrates Strong Support for the SImmetry® Sacroiliac Joint Fusion System
Mar 15, 2022 04:01PM Surgalign Holdings, Inc. Announces Fourth Quarter and Full Year 2021 Results
Mar 15, 2022 04:01PM Surgalign Holdings, Inc. Announces Fourth Quarter and Full Year 2021 Results
Mar 8, 2022 04:30PM Surgalign Holdings, Inc. Schedules Fourth Quarter and Full Year 2021 Earnings Release for March 15, 2022
Mar 8, 2022 04:30PM Surgalign Holdings, Inc. Schedules Fourth Quarter and Full Year 2021 Earnings Release for March 15, 2022
Mar 4, 2022 09:00AM Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Mar 4, 2022 09:00AM Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
View More Recent Stories View Older Stories